NYU Langone Perlmutter Cancer Center Welcomes New Chair of Radiation Oncology

The NYU Langone Perlmutter Cancer Center has made a significant appointment in its leadership, naming Dr. Daniel Gomez, MD, MBA, as the new Chair of the Department of Radiation Oncology. Dr. Gomez, known for his extensive work in the field, will step into this prestigious role after serving at Memorial Sloan Kettering Cancer Center, where he held high-ranking positions including attending physician and Director of Thoracic Radiation Oncology.

In his new capacity at NYU Grossman School of Medicine, Dr. Gomez will head multidisciplinary teams of researchers and clinicians dedicated to advancing cancer care. His focus will be on delivering world-class research alongside innovative treatment options for patients battling various forms of cancer. Dr. Gomez is particularly recognized for his specialized experience in managing oligometastatic cancers—those that have spread to limited areas within the body. This specialized focus represents a complex and crucial intersection of therapies, where coordination across multiple medical disciplines is vital.

Dr. Oren Cahlon, executive vice president and vice dean for clinical affairs at NYU Langone, expressed high praise for Dr. Gomez, stating, "He is an exceptional physician and researcher who is passionate about integrating research insights into patient care. His proven leadership skills in the area of radiation therapy will enhance our commitment to achieving the best outcomes for our patients."

Expressing his enthusiasm for the role, Dr. Gomez remarked, "I am truly honored to join NYU Langone Perlmutter Cancer Center. The energy and passion here to enhance cancer care motivates me deeply. The dedication of the Department of Radiation Oncology to offer personalized, compassionate treatment is inspiring. I look forward to contributing to this amazing team."

Dr. Gomez’s educational background is impressive, combining economics, medicine, and business. He holds a bachelor's degree in economics from the University of Virginia and an MD from the University of California, San Francisco. His residency in radiation oncology was completed at Memorial Sloan Kettering Cancer Center, followed by a Doris Duke research fellowship at Columbia University and an MBA from Rice University. Additionally, he has pursued further training focused on the applications of artificial intelligence in healthcare.

His professional journey has seen him excel at The University of Texas MD Anderson Cancer Center, where his roles included associate professor and leadership positions related to thoracic radiation oncology. His work at Memorial Sloan Kettering paved the way for his current appointment, reinforcing his credentials as a leader in the field.

Dr. Gomez's research to date has revolved around lung cancer and the application of radiation therapy in oligometastatic disease. His work has contributed significantly to the understanding of biomarker-integrated strategies and local ablative modalities. His leadership in numerous trials, including the evaluation of radiation combined with immunotherapy, showcases his commitment to advancing clinical practices. Notably, he co-led the large randomized NRG-LU002 trial that focused on local consolidative therapy for oligometastatic non-small cell lung cancer.

Dr. Gomez is widely published, with numerous peer-reviewed articles to his credit, further solidifying his role as a thought leader in radiation oncology. His wide-ranging impact on clinical standards and trial design showcases his deep commitment to transforming the future of cancer care.

This leadership change at NYU Langone Perlmutter Cancer Center marks a promising advancement in their ongoing mission to provide innovative, individualized care to cancer patients. With Dr. Gomez at the helm of radiation oncology, the center strengthens its dedication to delivering excellence in patient outcomes and pioneering research.

For media inquiries, contact Ryan Dziuba at (212)-404-4131 or [email protected].